Delivery Order SPE2DB24D2205-SPE2DB25FEDZA
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order valued at $27,852.48 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,990.72 firm fixed-price delivery order is for the supply of 60 capsules of 300 mg Rifampin, a medication used to treat certain bacterial infections. The contract has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,565,453,612 units of the drug Rifampin 300 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $13,361.76 and has an ultimate completion date of August 15, 2024. The contract is not designated as a Set-Aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,673.45 firm fixed-price delivery order is for the supply of 60 capsules of the antibiotic Rifampin 300mg. The contract has an ultimate completion date of March 12, 2025 and was awarded on February 12, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV7CD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,360.66 firm fixed-price delivery order is for the supply of 60 counts of 300 mg Rifampin capsules. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 60 capsules of 300 mg Rifampin. The single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,084.70 firm fixed-price delivery order covers the supply of 60 capsules of Rifampin 300 mg, a medication used to treat certain bacterial infections. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,648.47, is for the delivery of 4,567,529,290 units of Rifampin 300mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,530.51 firm fixed-price delivery order is for the supply of 60 capsules of 300 mg Rifampin, a medication used to treat certain bacterial infections. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,782.72 firm fixed-price delivery order is for the supply of 300 mg Rifampin capsules. The contract has an ultimate completion date of February 7, 2025 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEDZADelivery Order
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 60 capsules of Rifampin 300 mg. The contract has a firm fixed price of $11,677.35 and a completion date of June 24, 2025. The award was made on June 23, 2025 by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the company's ability to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 6/23/25 |